NovoPedics, Inc. has developed MeniscoFix™, a bioresorbable scaffold designed for total meniscus replacement. This innovative device utilizes a polymer fiber-reinforced design that mimics the structure of the native meniscus, allowing it to be gradually absorbed by the body and replaced with new tissue. MeniscoFix™ is engineered to attach to both soft tissue and bone, which enhances its potential application in total meniscus replacement surgeries. This technology addresses a significant medical need, as there are currently no FDA-approved products specifically for meniscus replacement, and it aims to restore mobility for patients suffering from severe meniscal injuries.

The MeniscoFix™ scaffold has demonstrated promising results in pre-clinical studies, which were supported by various grants, including those from the Department of Defense and the National Institutes of Health. The unique fiber-reinforced design not only provides structural support but also facilitates the healing process by integrating with the body’s natural tissues. NovoPedics' approach represents a significant advancement in the treatment of meniscal injuries, offering a potential alternative to traditional methods such as allograft tissue replacement and knee surgeries.

United States

NovoPedics, Inc. is developing implantable medical devices designed to relieve pain and restore mobility to patients suffering from severe meniscal injuries and meniscectomies. 

MeniscoFix™ is a polymer fiber-reinforced scaffold for total meniscus replacement designed to be gradually resorbed by the body and be replaced by new tissue. It represents an innovative approach to replace damaged meniscal tissue with a patented fiber-reinforced design similar to the native meniscus. It is designed to be attached to both soft tissue and bone, thus potentially enabling its use in total meniscus replacement surgery.

NovoPedics, Inc.

Company Details